136 results on '"Artini PG"'
Search Results
2. Cyclophosphamide induced gonadotoxicity and SIRT1: protective effect of crocetin, a natural bioactive compound derived from saffron
- Author
-
Di Emidio, G, Vitti, M, Di Carlo, M, Rossi, G, Artini, Pg, Sferra, R, Vetuschi, A, Carta, G, D’Alessandro, Am, and Tatone, C.
- Published
- 2016
3. Investigation of PPAR signalling in human granulosa cells (hGCs) obtained from IVF patients under different regimens of ovarian stimulation
- Author
-
Vitti, M, Benedetti, E, Di Emidio, G, Di Carlo, M, Vento, M, Ciriminna, R, Cimini, Anna Maria, Artini, Pg, and Tatone, Carla
- Published
- 2014
4. SIRT1, the main component of sirtuin family, protects mouse oocytes from oxidative stress and is deregulated with aging
- Author
-
Di Emidio, G, Falone, S, Vitti, M, Santonocito, M, Vento, M, Artini, Pg, DI PIETRO, Cinzia Santa, Amicarelli, F, and Tatone, C.
- Published
- 2013
5. Valutazione degli effetti della somministrazione di acido folico in pazienti sottoposte alla fecondazione assistita
- Author
-
Artini, Pg, Monteleone, P, Falone, S, Amicarelli, F, D'Alessandro, Anna Maria, Genazzani, A, and Tatone, Carla
- Published
- 2011
6. Oxidative stress after vitrification of young and aged mouse oocytes
- Author
-
Tatone, Carla, Di Emidio, G, Vento, M, Ciriminna, R, and Artini, Pg
- Published
- 2010
7. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients
- Author
-
Persico, N, Mancini, F, Artini, Pg, De Iaco, P, Volpe, Annibale, De Aloysio, D, Battaglia, C., N. Persico, F.Mancini, P.G. Artini, P. Deiaco, A.Volpe, D.de Aloysio, and C.Battaglia
- Subjects
hypertension ,HRT ,Urinary Bladder ,Medroxyprogesterone Acetate ,Administration, Cutaneous ,Ophthalmic Artery ,Humans ,Doppler ,plasma viscosity ,thromboxane ,ultrasound ,Analysis of Variance ,Estradiol ,Estrogen Replacement Therapy ,Uterus ,Ultrasonography, Doppler ,Arteries ,Middle Aged ,Blood Viscosity ,Postmenopause ,Thromboxane B2 ,Regional Blood Flow ,Case-Control Studies ,Hypertension ,Linear Models ,Female ,Vascular Resistance ,Carotid Artery, Internal - Abstract
To evaluate the effects of transdermal hormone replacement therapy (HRT) on plasma viscosity, serum levels of thromboxane B2 (TXB2) and vascular impedance in the uterine, bladder wall, internal carotid and ophthalmic arteries in normotensive and hypertensive postmenopausal patients.Thirty postmenopausal patients underwent continuous estradiol transdermal supplementation at a dose of 50 microg/day and 12-day courses of medroxyprogesterone acetate 10 mg/day every 2 months. The women were divided into two groups according to their blood pressure: normotensive women (Group 1, n=14) and hypertensive subjects (Group 2, n=16). Before starting HRT and after 6 months of therapy, the patients underwent: transvaginal ultrasonographic examination of the pelvic organs; Doppler examination of the blood flow velocities in the uterine, bladder wall, internal carotid and ophthalmic arteries; and analysis of plasma viscosity and plasma TXB2.After 6 months of HRT plasma viscosity had decreased in both groups (mean reduction in Group 1, (14+/-1)%, P=0.005; mean reduction in Group 2, (10+/-1)%, P=0.005) as had the TXB2 levels (mean reduction in Group 1, (93+/-2)%, P0.001; mean reduction in Group 2, (92+/-3)%, P0.001). The mean percentage reduction in plasma viscosity was smaller in hypertensive women than in normotensive women (P0.05). There was also a significant reduction in vascular impedance in the uterine artery (mean reduction in Group 1, (16+/-1)%, P=0.005; mean reduction in Group 2, (19+/-1)%, P=0.005), the bladder wall arteries (mean reduction in Group 1, (23+/-2)%, P=0.005; mean reduction in Group 2, (18+/-1)%, P=0.005), the internal carotid artery (mean reduction in Group 1, (25+/-1)%, P=0.005; mean reduction in Group 2, (26+/-1)%, P=0.005) and the ophthalmic artery (mean reduction in Group 1, (24+/-2)%, P=0.005; mean reduction in Group 2, (16+/-1)%, P=0.005). The percentage reduction in vascular impedance did not differ significantly between the two groups.Our results show that transdermal HRT is effective in reducing plasma viscosity, TXB2 levels and vascular impedance in the peripheral and central vessels both in normotensive and hypertensive postmenopausal patients.
- Published
- 2005
8. Ultrasonographic and color doppler analysis in the treatment of polycystic ovary syndrome
- Author
-
Battaglia, C, Genazzani, Alessandro, Artini, Pg, Salvatori, M, Giulini, S, and Volpe, A.
- Subjects
Doppler ,PCOS ,therapy ,ultrasonography ,hirsutism ,GnRH-A - Published
- 1998
9. Vascular endothelial growth factor and its soluble receptor in ovarian pathology
- Author
-
Artini, PG, primary, Cristello, F, additional, Monti, M, additional, Cela, V, additional, Battaglia, C, additional, D'Ambrogio, G, additional, and Genazzani, AR, additional
- Published
- 2005
- Full Text
- View/download PDF
10. Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients
- Author
-
Persico, N, primary, Mancini, F, additional, Artini, PG, additional, Regnani, G, additional, Volpe, A, additional, Aloysio, D de, additional, and Battaglia, C, additional
- Published
- 2004
- Full Text
- View/download PDF
11. NAD + Metabolism and Mitochondrial Activity in the Aged Oocyte: Focus on the Effects of NAMPT Stimulation.
- Author
-
Di Emidio G, Vergara T, Konstantinidou F, Flati I, Stuppia L, Artini PG, Gatta V, Falone S, and Tatone C
- Abstract
The ovary experiences an age-dependent decline starting during the fourth decade of life. Ovarian aging is the predominant factor driving female reproductive aging. Modern trend to postpone childbearing age contributes to reduced fertility and natality worldwide. Recently, the beneficial role of NAD
+ precursors on the maintenance of oocyte competence and female fertility affected by aging has emerged. Nevertheless, age-related changes in NAD+ regulatory network have not been investigated so far. In this context, our goal was to investigate changes induced by the aging process in the expression level of genes participating in NAD+ biosynthetic and NAD+ consuming pathways and in the cellular bioenergetics in the mouse oocyte. From Ingenuity Pathway Analysis (IPA) it emerged that aging caused the downregulation of all cellular pathways for NAD+ synthesis (Kynurenine pathway, Preiss-Handler pathway and NAD+ salvage pathway) and deeply influenced the activity of NAD+ -dependent enzymes, i.e. PARPs and SIRTs, with effects on many cellular functions including compromised ROS detoxification. Considering that NAMPT, the rate-limiting enzyme of NAD+ salvage pathway, was deregulated, aged oocytes were matured in the presence of P7C3, NAMPT activator. P7C3 improved spindle assembly and mitochondrial bioenergetics and reduced mitochondrial proton leak. Moreover, P7C3 influenced gene expression of NAD+ regulatory network, with Sirt1 as the central node of IPA-interfered target gene network. Finally, P7C3 effectively counteracted oocyte alterations induced by exposure to oxidative stress. Our study contributes to establish effective NAD+ boosting interventions to alleviate the effects of advanced maternal age on fertility and explore their potential in redox-related fertility disorders.- Published
- 2024
- Full Text
- View/download PDF
12. Maternal MicroRNA Profile Changes When LH Is Added to the Ovarian Stimulation Protocol: A Pilot Study.
- Author
-
Konstantinidou F, Placidi M, Di Emidio G, Stuppia L, Tatone C, Gatta V, and Artini PG
- Abstract
While the use of follicle-stimulating hormone (FSH) in ovarian stimulation for in vitro fertilization (IVF) is an established practice, the use of luteinizing hormone (LH) remains debatable. MicroRNAs (miRNAs) are short, endogenous, non-coding transcripts that control a variety of cellular functions, such as gonadotrophin production and follicular development. The goal of this pilot study was to investigate whether the employment of recombinant LH (rLH) in ovarian stimulation protocols results in changes in the miRNA profiles in human oocytes. Patients were divided into two groups: seven received recombinant FSH (rFSH, 225 IU), and six received rFSH (150 IU) plus rLH (75 IU). MiRNA predesigned panels and real-time PCR technology were used to analyze the oocytes retrieved from the follicular ovarian retrieval. Among the miRNAs evaluated, a series of them evidenced upregulation or downregulation in their expression in the FSH plus LH group compared to the FSH group. Considering the results obtained from the functional and network analysis, the different maternal miRNA profiles in the two groups revealed a differential modulation of pathways involved in numerous biological functions. Overall, based on the pathways associated with most of these maternal miRNAs, the presence of LH may result in a different modulation of pathways regulating survival under the control of a Tp53-related mechanism. Interestingly, among the miRNAs differentially expressed in oocytes of the two groups, we have found miRNAs already investigated at ovarian, follicular, oocyte, and embryonic levels: hsa-miR-484, hsa-miR-222, hsa-miR-520d-5p, hsa-miRNA-17, hsa-miR-548, and hsa-miR-140. Thus, investigation into the role of these miRNAs in oocyte molecular pathways may help determine how LH affects oocyte competence and eventually leads to the clinical improvement of IVF.
- Published
- 2023
- Full Text
- View/download PDF
13. Acyl-Carnitines Exert Positive Effects on Mitochondrial Activity under Oxidative Stress in Mouse Oocytes: A Potential Mechanism Underlying Carnitine Efficacy on PCOS.
- Author
-
Placidi M, Vergara T, Casoli G, Flati I, Capece D, Artini PG, Virmani A, Zanatta S, D'Alessandro AM, Tatone C, and Di Emidio G
- Abstract
Carnitines play a key physiological role in oocyte metabolism and redox homeostasis. In clinical and animal studies, carnitine administration alleviated metabolic and reproductive dysfunction associated with polycystic ovarian syndrome (PCOS). Oxidative stress (OS) at systemic, intraovarian, and intrafollicular levels is one of the main factors involved in the pathogenesis of PCOS. We investigated the ability of different acyl-carnitines to act at the oocyte level by counteracting the effects of OS on carnitine shuttle system and mitochondrial activity in mouse oocytes. Germinal vesicle (GV) oocytes were exposed to hydrogen peroxide and propionyl-l-carnitine (PLC) alone or in association with l-carnitine (LC) and acetyl-l-carnitine (ALC) under different conditions. Expression of carnitine palmitoyltransferase-1 (Cpt1) was monitored by RT-PCR. In in vitro matured oocytes, metaphase II (MII) apparatus was assessed by immunofluorescence. Oocyte mitochondrial respiration was evaluated by Seahorse Cell Mito Stress Test. We found that Cpt1a and Cpt1c isoforms increased under prooxidant conditions. PLC alone significantly improved meiosis completion and oocyte quality with a synergistic effect when combined with LC + ALC. Acyl-carnitines prevented Cpt1c increased expression, modifications of oocyte respiration, and ATP production observed upon OS. Specific effects of PLC on spare respiratory capacity were observed. Therefore, carnitine supplementation modulated the intramitochondrial transfer of fatty acids with positive effects on mitochondrial activity under OS. This knowledge contributes to defining molecular mechanism underlying carnitine efficacy on PCOS.
- Published
- 2023
- Full Text
- View/download PDF
14. Molecular Research on Polycystic Ovary Syndrome (PCOS).
- Author
-
Daniele S, Chelucci E, Scarfò G, and Artini PG
- Abstract
Polycystic ovary syndrome (PCOS) is an endocrine systemic disorder with a prevalence of between 5% and 20% that commonly affects childbearing-aged women [...].
- Published
- 2023
- Full Text
- View/download PDF
15. Oxidative Stress-Related Signaling Pathways Predict Oocytes' Fertilization In Vitro and Embryo Quality.
- Author
-
Artini PG, Scarfò G, Marzi I, Fusi J, Obino ME, Franzoni F, Zappelli E, Chelucci E, Martini C, Cela V, and Daniele S
- Subjects
- Female, Animals, Oocytes metabolism, Follicular Fluid metabolism, Fertilization in Vitro methods, Oxidative Stress, Signal Transduction, Interleukin-10 metabolism, Antioxidants metabolism
- Abstract
Oocyte development and fertilization are largely influenced by the microenvironment of the follicular fluid (FF), and the exploration of its molecular/metabolic composition may help in improving in vitro fertilization (IVF) outcomes. Here, the concentrations of molecules related to oxidative stress/inflammation were measured in FF from follicles at oocyte retrieval during IVF. Here, the FF antioxidant potential was correlated with the number of retrieved/mature oocytes and the number of fertilized ones. FF collected from the follicles of normal fertilized oocytes presented an elevated antioxidant capability, lower levels of pro-inflammatory molecules (i.e., IL-6, IL-8, IL-12, TGF-β, and HIF-1α), and a higher IL-10 concentration. FF samples from follicles at oocyte retrieval that resulted in top-quality embryos displayed a peculiar antioxidant capability and a further decrease in proinflammatory molecules when compared with FF, giving rise to poor-quality embryos. Finally, pro-inflammatory molecules were lower and accompanied by a high antioxidant capability in samples giving rise to successful embryo implantation. The antioxidant capability and IL-10 displayed a good predictive ability for fertilization and embryo quality. Overall, our data showed the great influence of oxidative stress on the oocytes' fertilization, and shed light on the importance of controlling the inflammatory and oxidative status of FF to obtain good-quality embryos with significant implantation potential.
- Published
- 2022
- Full Text
- View/download PDF
16. Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.
- Author
-
Scarfò G, Daniele S, Fusi J, Gesi M, Martini C, Franzoni F, Cela V, and Artini PG
- Abstract
Polycystic ovary syndrome (PCOS) is an endocrine systemic disorder mainly characterized by a hormonal and metabolic disbalance that leads to oligo/anovulation, hyperandrogenism and the formation of ovarian cysts. Despite the progress that has been reached in its diagnosis and management, little is known about the molecular mechanisms and signaling pathways underlying the pathogenic mechanisms. In this sense, recent research has suggested that the influence of multiple factors, including age, environment, lifestyle and the disease state environment can change the clinical presentation of PCOS via epigenetic modifications. Variants in the genes encoding for proteins involved in steroidogenesis and glucose homeostasis play a crucial role in the development of the disease. Other genes involved in inflammation and cell proliferation seem to undergo an epigenetic control. Moreover, lifestyle factors influence the PCOS course and prognosis, including diet and physical activity, which are fundamental in reducing oxidative stress, inflammation and in improving metabolic and hormonal parameters. In the present review, literature evidence on molecular and epigenetic mechanisms related to PCOS etiology will be discussed, with a particular attention on the positive influence of diet and physical activity as nonpharmacological ways of intervention in the management of the disease.
- Published
- 2022
- Full Text
- View/download PDF
17. Endometrial Dysbiosis Is Related to Inflammatory Factors in Women with Repeated Implantation Failure: A Pilot Study.
- Author
-
Cela V, Daniele S, Obino MER, Ruggiero M, Zappelli E, Ceccarelli L, Papini F, Marzi I, Scarfò G, Tosi F, Franzoni F, Martini C, and Artini PG
- Abstract
An abnormal endometrial microbiota has been suggested to impair the process of embryo implantation, thus leading to repeated implantation failure (RIF) in women undergoing in vitro fertilization (IVF). However, the molecular mechanisms linking uterine microbiota and IVF out-comes are still an open question. The aim of this cohort study was to outline the relationship between endometrial microbiota, inflammation and IVF outcomes. To this purpose, endometrial microbiota and selected components of the “cytokine network” were analyzed in women presenting RIF and divided between eubiosis and dysbiosis groups, according to the percentage of endometrial lactobacilli (≥90% or <90%, respectively). The Dysbiosis group presented significantly higher tissue concentrations of the inflammatory markers (IL-6, IL-1β, HIF-1α and COX-2) and significantly lower levels of the anti-inflammatory/well-being factors, IL-10 and IGF-1, with respect to women with eubiosis. Moreover, the Lactobacillus percentage was negatively related to the concentrations of the inflammatory molecules and positively related to IL-10/IGF-1. Interestingly, the number of IVF attempts was directly related to the levels of the inflammatory factors COX-2, IL-1β and HIF-1α in the eubiosis group. Overall, endometrial dysbiosis was demonstrated to be associated with inflammation-related endometrial changes affecting the process of embryo implantation, underlining the importance of assessing uterine microbiota in patients undergoing IVF.
- Published
- 2022
- Full Text
- View/download PDF
18. Carnitines as Mitochondrial Modulators of Oocyte and Embryo Bioenergetics.
- Author
-
Placidi M, Di Emidio G, Virmani A, D'Alfonso A, Artini PG, D'Alessandro AM, and Tatone C
- Abstract
Recently, the importance of bioenergetics in the reproductive process has emerged. For its energetic demand, the oocyte relies on numerous mitochondria, whose activity increases during embryo development under a fine regulation to limit ROS production. Healthy oocyte mitochondria require a balance of pyruvate and fatty acid oxidation. Transport of activated fatty acids into mitochondria requires carnitine. In this regard, the interest in the role of carnitines as mitochondrial modulators in oocyte and embryos is increasing. Carnitine pool includes the un-esterified l-carnitine (LC) and carnitine esters, such as acetyl-l-carnitine (ALC) and propionyl-l-carnitine (PLC). In this review, carnitine medium supplementation for counteracting energetic and redox unbalance during in vitro culture and cryopreservation is reported. Although most studies have focused on LC, there is new evidence that the addition of ALC and/or PLC may boost LC effects. Pathways activated by carnitines include antiapoptotic, antiglycative, antioxidant, and antiinflammatory signaling. Nevertheless, the potential of carnitine to improve energetic metabolism and oocyte and embryo competence remains poorly investigated. The importance of carnitine as a mitochondrial modulator may suggest that this molecule may exert a beneficial role in ovarian disfunctions associated with metabolic and mitochondrial alterations, including PCOS and reproductive aging.
- Published
- 2022
- Full Text
- View/download PDF
19. Oxidative Stress Measurement in Frozen/Thawed Human Sperm: The Protective Role of an In Vitro Treatment with Myo-Inositol.
- Author
-
Ponchia R, Bruno A, Renzi A, Landi C, Shaba E, Luongo FP, Haxhiu A, Artini PG, Luddi A, Governini L, and Piomboni P
- Abstract
Despite its widespread use, sperm cryopreservation induces serious detrimental alterations in sperm function; indeed, it is commonly associated with decreased sperm viability and motility, and DNA fragmentation. Mechanisms of human sperm cryodamage are thought to be multifactorial, but oxidative stress seems to have a prominent role. A huge amount of data supported the cryoprotective effect of different antioxidants able to minimize the detrimental effects of reactive oxygen species (ROS) and improve the quality of spermatozoa. Among others, myo-inositol is one of the most powerful and has been reported to be effective in improving sperm quality and motility when used both in vivo and in vitro. This study aimed to determine the in vitro impact of myo-inositol in ameliorating sperm oxidative status during sperm cryopreservation. In particular, we demonstrated a significant improvement of sperm parameters (vitality and motility) when myo-inositol was added after sperm thawing ( p < 0.05). Moreover, we showed that myo-inositol induces a significant increase in oxygen consumption, the main index of oxidative phosphorylation efficiency and ATP production. Finally, by means of 2D-electrophoresis, we demonstrated a significant decrease in the level of carbonyl groups, the main structural changes occurring in conditions of oxidative stress ( p < 0.05). In conclusion, the sperm cryopreservation procedure we developed, assuring the reduction of ROS-induced sperm modifications, may improve the in vitro procedure currently used in ART laboratory for sperm cryostorage.
- Published
- 2021
- Full Text
- View/download PDF
20. Exploring Epithelial-Mesenchymal Transition Signals in Endometriosis Diagnosis and In Vitro Fertilization Outcomes.
- Author
-
Cela V, Malacarne E, Obino MER, Marzi I, Papini F, Vergine F, Pisacreta E, Zappelli E, Pietrobono D, Scarfò G, Daniele S, Franzoni F, Martini C, and Artini PG
- Abstract
Endometriosis (EMS) pathogenesis has been related to the release of inflammatory mediators in peritoneal fluid, creating an altered microenvironment that leads to low-grade oocyte/embryos and to the reduction of implantation rates. The Epithelial-Mesenchymal Transition (EMT), an inflammation-related process, can be a further contributing factor to EMS. This study aimed to investigate, among various cytokines and EMT markers (Cadherins, TGF-β, HIF-1α), diagnostic markers of EMS and prognostic factors of in vitro fertilization (IVF) outcomes. Herein, EMS patients manifested higher serum levels of the inflammatory molecules IL-6, IL-8, and IL-12 and a decrease in the concentrations of the anti-inflammatory IL-10. Moreover, biochemical markers associated with the EMT process were more elevated in serum and follicular fluid (FF) of EMS patients than in controls. At the end, the number of good-quality embryos was inversely related to serum IL-6 and EMT markers. Interestingly, serum IL-6 and FF IL-10 concentrations differentiated EMS patients from controls. Finally, serum IL-8 and E-Cadherin levels, as well as FF IL-10, predicted positive IVF outcome with great accuracy. Our data confirm the pivotal role of inflammatory mediators (i.e., IL-6 and IL-10) in EMS pathogenesis and suggest that EMT-related markers are elevated in EMS patients and can be predictive of IVF outcome.
- Published
- 2021
- Full Text
- View/download PDF
21. The relevance of inositols treatment for PCOS before and during ART.
- Author
-
Artini PG, Malacarne E, Tomatis V, and Genazzani AD
- Subjects
- Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome metabolism, Inositol pharmacology, Polycystic Ovary Syndrome drug therapy, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Polycystic ovary syndrome (PCOS) is an endo-crine disorder that occurs in 8-10% of women of reproduc-tive age. It is characterized by oligo or anovulation, hyperandrogenism and/or polycystic ovaries, but also by an increased insulin plasma level especially in overweight/obese women or in those with familial diabetes. In the last years, among the insulin sensitizers, the use of the two active isoforms of inositols (myo-inositol and d-chiro-inositol) has been spreading for the treatment of PCOS insulin resistance. Several studies have shown a positive role of inositols both on the metabolic profile of PCOS patients, but also on hormonal parameters. Hence, inositols can positively affect the infertility that characterizes many PCOS patients, acting both on ovarian function and spontaneous ovulation and during IVF procedures, in terms of oocyte quality and pregnancy rate.
- Published
- 2021
- Full Text
- View/download PDF
22. Mitochondrial Sirtuins in Reproduction.
- Author
-
Di Emidio G, Falone S, Artini PG, Amicarelli F, D'Alessandro AM, and Tatone C
- Abstract
Mitochondria act as hubs of numerous metabolic pathways. Mitochondrial dysfunctions contribute to altering the redox balance and predispose to aging and metabolic alterations. The sirtuin family is composed of seven members and three of them, SIRT3-5, are housed in mitochondria. They catalyze NAD+-dependent deacylation and the ADP-ribosylation of mitochondrial proteins, thereby modulating gene expression and activities of enzymes involved in oxidative metabolism and stress responses. In this context, mitochondrial sirtuins (mtSIRTs) act in synergistic or antagonistic manners to protect from aging and aging-related metabolic abnormalities. In this review, we focus on the role of mtSIRTs in the biological competence of reproductive cells, organs, and embryos. Most studies are focused on SIRT3 in female reproduction, providing evidence that SIRT3 improves the competence of oocytes in humans and animal models. Moreover, SIRT3 protects oocytes, early embryos, and ovaries against stress conditions. The relationship between derangement of SIRT3 signaling and the imbalance of ROS and antioxidant defenses in testes has also been demonstrated. Very little is known about SIRT4 and SIRT5 functions in the reproductive system. The final goal of this work is to understand whether sirtuin-based signaling may be taken into account as potential targets for therapeutic applications in female and male infertility.
- Published
- 2021
- Full Text
- View/download PDF
23. Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
- Author
-
Battaglia C, Battaglia B, Casadio P, Rizzo R, and Artini PG
- Subjects
- Adult, Blood Glucose metabolism, Brachial Artery physiopathology, Female, Glucose Tolerance Test, Humans, Hyperinsulinism metabolism, Hyperinsulinism physiopathology, Insulin Resistance, Longitudinal Studies, Ophthalmic Artery diagnostic imaging, Pilot Projects, Polycystic Ovary Syndrome metabolism, Polycystic Ovary Syndrome physiopathology, Retrospective Studies, Ultrasonography, Doppler, Vasodilation, Young Adult, Contraceptive Agents, Hormonal administration & dosage, Contraceptive Devices, Female, Desogestrel administration & dosage, Ethinyl Estradiol administration & dosage, Hyperinsulinism drug therapy, Hypoglycemic Agents therapeutic use, Metformin therapeutic use, Polycystic Ovary Syndrome drug therapy
- Abstract
Purpose: The aim of this longitudinal, controlled, and retrospective pilot study was to assess how metformin, associated with a contraceptive vaginal ring, may influence lipid and carbohydrate metabolism, and surrogate markers of arterial function in normal weight polycystic ovary syndrome patients., Material and Methods: Among 28 lean patients, 15 were treated with vaginal ring plus metformin and 13 women with only vaginal ring. The effects were assessed after six months. The patients were submitted to evaluation of lipid and carbohydrate metabolism; Doppler analysis of ophthalmic artery; brachial artery flow-mediated vasodilatation; and oral glucose tolerance test., Results: After six months, the fasting insulin, glucose/insulin ratio, and homeostatic model assessment estimates for insulin resistance were significantly improved in metformin group. The ophthalmic artery pulsatility index did not significantly improve in either group. The brachial artery vasodilation was better in metformin treated patients., Conclusion: Metformin, associated with vaginal ring, improves the insulin and carbohydrate metabolism. This, associated with the significant improvements of surrogate markers of arterial function, may be responsible of a slight possible cardiovascular and cerebrovascular protective effect.
- Published
- 2020
- Full Text
- View/download PDF
24. Regulatory Functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS Mouse Model: Focus on Antioxidant/Antiglycative Molecular Pathways in the Ovarian Microenvironment.
- Author
-
Di Emidio G, Rea F, Placidi M, Rossi G, Cocciolone D, Virmani A, Macchiarelli G, Palmerini MG, D'Alessandro AM, Artini PG, and Tatone C
- Abstract
Polycystic ovary syndrome (PCOS) is a complex metabolic disorder associated with female infertility. Based on energy and antioxidant regulatory functions of carnitines, we investigated whether acyl-L-carnitines improve PCOS phenotype in a mouse model induced by dehydroepiandrosterone (DHEA). CD1 mice received DHEA for 20 days along with two different carnitine formulations: one containing L-carnitine (LC) and acetyl-L-carnitine (ALC), and the other one containing also propionyl-L-carnitine (PLC). We evaluated estrous cyclicity, testosterone level, ovarian follicle health, ovulation rate and oocyte quality, collagen deposition, lipid droplets, and 17ß-HSD IV (17 beta-hydroxysteroid dehydrogenase type IV) expression. Moreover, we analyzed protein expression of SIRT1, SIRT3, SOD2 (superoxide dismutase 2), mitochondrial transcriptional factor A (mtTFA), RAGE (receptor for AGEs), GLO2 (glyoxalase 2) and ovarian accumulation of MG-AGEs (advanced glycation end-products formed by methylglyoxal). Both carnitine formulations ameliorated ovarian PCOS phenotype and positively modulated antioxidant molecular pathways in the ovarian microenvironment. Addition of PLC to LC-ALC formulation mitigated intraovarian MG-AGE accumulation and increased mtTFA expression. In conclusion, our study supports the hypothesis that oral administration of acyl-L-carnitines alleviates ovarian dysfunctions associated with this syndrome and that co-administration of PLC provides better activity. Molecular mechanisms underlying these effects include anti-oxidant/glycative activity and potentiation of mitochondria.
- Published
- 2020
- Full Text
- View/download PDF
25. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
- Author
-
Artini PG, Obino MER, Micelli E, Malacarne E, Vacca C, Papini F, and Cela V
- Subjects
- Adult, Drug Therapy, Combination, Female, Fertility Agents, Female therapeutic use, Fertilization in Vitro methods, Gonadotropin-Releasing Hormone antagonists & inhibitors, Humans, Infertility, Female etiology, Inositol chemistry, Inositol pharmacology, Obesity complications, Obesity therapy, Overweight complications, Overweight therapy, Polycystic Ovary Syndrome complications, Pregnancy, Pregnancy Outcome, Retrospective Studies, Thioctic Acid pharmacology, Treatment Outcome, Infertility, Female therapy, Inositol administration & dosage, Ovulation Induction adverse effects, Ovulation Induction methods, Polycystic Ovary Syndrome therapy, Thioctic Acid administration & dosage
- Abstract
Insulin resistance (IR) plays a central role in the onset of polycystic ovary syndrome (PCOS). Insulin so insulin-sensitizing like inositols have been proposed as first line therapy. Among them d-chiro-inositol (DCI) seems to improve glucose metabolism and to increase ovulation frequency. Other studies have demonstrated that alpha-lipoic acid (ALA), with its antioxidant role, can also improve endocrine and metabolic profile of PCOS patients especially with familial diabetes. This a retrospective observational study with the aim to evaluate possible advantages of an integrative preparation combining DCI 500 mg and ALA 300 mg in overweight/obese PCOS patients with or without diabetic relatives who underwent IVF. Twenty PCOS patients who were taking the integrative preparation underwent controlled ovarian hyperstimulation in our center. The group with diabetic relatives tended to have a lower dose of gonadotropin, shorter stimulation days, higher number of MII oocytes, and higher number of fertilized oocytes. A combined regimen of DCI and ALA could be an interesting strategy in overweight PCOS patients with familial diabetes underwent ART.
- Published
- 2020
- Full Text
- View/download PDF
26. Respiratory Mitochondrial Efficiency and DNA Oxidation in Human Sperm after In Vitro Myo-Inositol Treatment.
- Author
-
Governini L, Ponchia R, Artini PG, Casarosa E, Marzi I, Capaldo A, Luddi A, and Piomboni P
- Abstract
Semen samples are known to contain abnormal amounts of reactive oxygen species (ROS) and oxygen free radicals; therefore, the identification of antioxidant molecules able to counteract the oxidative damage caused by ROS is foresight. Indeed, improving semen quality in terms of motility and reduction in DNA damage, can significantly improve the fertilization potential of sperm in vitro. To this regard, myo-inositol, based on its antioxidant properties, has been reported to be effective in improving sperm quality and motility in oligoasthenozoospermic patients undergoing assisted reproduction techniques when used as a dietary supplementation. Moreover, in vitro treatment demonstrated a direct relationship between myo-inositol, mitochondrial membrane potential and sperm motility. This experimental study aimed to evaluate the effects of myo-inositol (Andrositol-lab) in vitro treatment on sperm motility, capacitation, mitochondrial oxidative phosphorylation and DNA damage. Our results demonstrate that myo-inositol induces a significant increase in sperm motility and in oxygen consumption, the main index of oxidative phosphorylation efficiency and ATP production, both in basal and in in vitro capacitated samples. Moreover, we provide evidence for a significant protective role of myo-inositol against oxidative damage to DNA, thus supporting the in vitro use of myo-inositol in assisted reproductive techniques. Even if further studies are needed to clarify the mechanisms underlying the antioxidant properties of myo-inositol, the present findings significantly extend our knowledge on human male fertility and pave the way to the definition of evidence-based guidelines, aiming to improve the in vitro procedure currently used in ART laboratory for sperm selection.
- Published
- 2020
- Full Text
- View/download PDF
27. 'Primary gingival and later primary vulval carcinomas arising in lichen planus: report of a case and clinical suggestions for diagnosis of a neglected disease'.
- Author
-
Basile S, Pinelli S, Bottone P, Artini PG, Plotti F, and Panici PB
- Subjects
- Aged, Carcinoma, Squamous Cell diagnosis, Female, Humans, Neoplasms, Second Primary diagnosis, Vulvar Neoplasms diagnosis, Carcinoma, Squamous Cell etiology, Gingival Neoplasms etiology, Lichen Planus complications, Neoplasms, Second Primary etiology, Vulvar Neoplasms etiology
- Abstract
Lichen planus (LP) is a chronic immune-mediated dermatosis mainly affecting skin, oral, and genital mucosa. The heterogeneous clinical presentation, spectrum of symptoms depending on subtype and overlap with other vulval and cutaneous disorders can lead to challenging in diagnosis. We report an unusual case of vulval SCC arising within a patient with initial oral mucosal lichen planus who later developed lichen planus of the vulva. Discussion of this case is important as it typifies the difficulties in diagnosis of vulvo-vaginal disorders and potential complications. Evidence is available that lichen planus may be potentially precancerous condition and is associated with SCC development. This case may confirm an inherent oncologic potential of the disease. All efforts must be made by specialists involved in the management of this disease to obtain an early diagnosis, ensure proper treatment and adequate follow up. This highlights the need to perform vulval examination in patients with symptoms or with a history muco-cutaneous LP and if necessary consider referral to specialist center for biopsy and management.
- Published
- 2019
- Full Text
- View/download PDF
28. Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects.
- Author
-
Di Emidio G, D'Aurora M, Placidi M, Franchi S, Rossi G, Stuppia L, Artini PG, Tatone C, and Gatta V
- Subjects
- Animals, Female, Kruppel-Like Transcription Factors genetics, Kruppel-Like Transcription Factors metabolism, Male, Mice, Oocytes metabolism, RNA, Long Noncoding genetics, RNA, Long Noncoding metabolism, Receptor, IGF Type 2 genetics, Receptor, IGF Type 2 metabolism, Cyclophosphamide pharmacology, DNA Methylation, Genomic Imprinting, Maternal Exposure, Mutagens pharmacology, Oocytes drug effects
- Abstract
Cyclophosphamide (CPM), an agent widely used in breast cancer therapy, has strong gonadotoxic effects. Female reproductive potential after therapy relies on ovulated oocytes deriving from primordial follicles surviving CPM toxic insult. In this study, we investigated in the mouse model whether pre-conceptional maternal exposure to CPM has epigenetic effects on offspring oocytes and if they are inherited. Adult female mice mated following CPM exposure, generated an offspring (F1) with delayed growth, normal fertility and altered methylation of three imprinted genes ( H19, Igf2r and Peg3 ) in their oocytes. These alterations were present in oocytes generated by F2 mice. Pre-conceptional maternal exposure to fertoprotective agents AS101 and crocetin prior to CPM was not able to fully counteract alterations in offspring oocyte imprinting. For the first time, current study evidences that pre-conceptional CPM maternal exposure can affect the competence of offspring's oocytes and warns on possible long-term effects on the health of next generations.
- Published
- 2019
- Full Text
- View/download PDF
29. SIRT1 participates in the response to methylglyoxal-dependent glycative stress in mouse oocytes and ovary.
- Author
-
Di Emidio G, Santini SJ, D'Alessandro AM, Vetuschi A, Sferra R, Artini PG, Carta G, Falone S, Amicarelli F, and Tatone C
- Subjects
- Animals, Benzamides pharmacology, Carbazoles pharmacology, Catalase genetics, Catalase metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Enzyme Inhibitors pharmacology, Female, Gene Expression Regulation, Glycation End Products, Advanced metabolism, Lactoylglutathione Lyase antagonists & inhibitors, Lactoylglutathione Lyase genetics, Lactoylglutathione Lyase metabolism, Mice, Mice, Inbred Strains, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, Naphthols pharmacology, Oocytes cytology, Oocytes metabolism, Ovary cytology, Ovary metabolism, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha genetics, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha metabolism, Primary Cell Culture, Pyruvaldehyde antagonists & inhibitors, Resveratrol pharmacology, Signal Transduction, Sirtuin 1 metabolism, Sirtuin 3 genetics, Sirtuin 3 metabolism, Superoxide Dismutase genetics, Superoxide Dismutase metabolism, Thiolester Hydrolases antagonists & inhibitors, Thiolester Hydrolases genetics, Thiolester Hydrolases metabolism, Transcription Factors genetics, Transcription Factors metabolism, Glycation End Products, Advanced genetics, Oocytes drug effects, Ovary drug effects, Pyruvaldehyde pharmacology, Sirtuin 1 genetics
- Abstract
Methylglyoxal (MG), a highly reactive dicarbonyl derived from metabolic processes, is the most powerful precursor of advanced glycation end products (AGEs). Glycative stress has been recently associated with ovarian dysfunctions in aging and PCOS syndrome. We have investigated the role of the NAD
+ -dependent Class III deacetylase SIRT1 in the adaptive response to MG in mouse oocytes and ovary. In mouse oocytes, MG induced up-expression of glyoxalase 1 (Glo1) and glyoxalase 2 (Glo2) genes, components of the main MG detoxification system, whereas inhibition of SIRT1 by Ex527 or sirtinol reduced this response. In addition, the inhibition of SIRT1 worsened the effects of MG on oocyte maturation rates, while SIRT1 activation by resveratrol counteracted MG insult. Ovaries from female mice receiving 100 mg/kg MG by gastric administration for 28 days (MG mice) exhibited increased levels of SIRT1 along with over-expression of catalase, superoxide dismutase 2, SIRT3, PGC1α and mtTFA. Similar levels of MG-derived AGEs were observed in the ovaries from MG and control groups, along with enhanced protein expression of glyoxalase 1 in MG mice. Oocytes ovulated by MG mice exhibited atypical meiotic spindles, a condition predisposing to embryo aneuploidy. Our results from mouse oocytes revealed for the first time that SIRT1 could modulate MG scavenging by promoting expression of glyoxalases. The finding that up-regulation of glyoxalase 1 is associated with that of components of a SIRT1 functional network in the ovaries of MG mice provides strong evidence that SIRT1 participates in the response to methylglyoxal-dependent glycative stress in the female gonad., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
30. Corrigendum to "Inositol and In Vitro Fertilization with Embryo Transfer".
- Author
-
Simi G, Genazzani AR, Obino MER, Papini F, Pinelli S, Cela V, and Artini PG
- Abstract
[This corrects the article DOI: 10.1155/2017/5469409.].
- Published
- 2019
- Full Text
- View/download PDF
31. Assisted reproductive technique in women of advanced fertility age.
- Author
-
Artini PG, Obino ME, Vergine F, Sergiampietri C, Papini F, and Cela V
- Subjects
- Aging physiology, Female, Humans, Infertility, Female etiology, Maternal Age, Oocytes physiology, Ovary physiology, Reproduction physiology, Fertilization in Vitro methods, Infertility, Female therapy, Reproductive Techniques, Assisted
- Abstract
Over the past four decades, the postponement of childbearing has continued to increase, significantly impacting the age of first-time mothers. Female age is the most significant factor influencing clinical outcome in in-vitro fertilization. To overcome the limits of the age-related decline of fertility is a challenge for fertility experts. In the decrease of fertility in late reproductive age, a lot of factors related with advancing women's age and general health can be considered, however the dominant regulator of this age-dependent loss of fertility is the ovary. The key factors in the ovarian aging are oxidative stress, abnormalities of the meiotic spindle, decrease of function and number of oocyte mitochondria, alteration of sirtuins and androgen deficiency. The aim of this review was to assess the main biological factors involved in the female reproductive ageing according to the recent literature, focusing on oocyte-dependent ones, as well as the possible therapeutic strategies in assisted reproductive technique.
- Published
- 2018
- Full Text
- View/download PDF
32. Human Breast Milk: Exploring the Linking Ring Among Emerging Components.
- Author
-
Bardanzellu F, Fanos V, Strigini FAL, Artini PG, and Peroni DG
- Abstract
Maternal breast milk (BM) is a complex and unique fluid that evolution adapted to satisfy neonatal needs; in addition to classical nutrients, it contains several bioactive components. BM characteristically shows inter-individual variability, modifying its composition during different phases of lactation. BM composition, determining important consequences on neonatal gut colonization, influences both short and long-term development. Maternal milk can also shape neonatal microbiota, through its glycobiome rich in Lactobacilli spp. and Bifidobacteria spp. Therefore, neonatal nourishment during the first months of life seems the most important determinant of individual's outcomes. Our manuscript aims to provide new evidence in the characterization of BM metabolome and microbiome, and its comparison to formula milk, allowing the evaluation of each nutrient's influence on neonatal metabolism. This result very interesting since potentially offers an innovative approach to investigate the complex relationship between BM components and infant's health, also providing the chance to intervene in a sartorial way on diet composition, according to the nutritional requests. Future research, integrating metabolomics, microbiomics and stem cells knowledge, could make significant steps forward in understanding BM extraordinary properties and functions.
- Published
- 2018
- Full Text
- View/download PDF
33. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
- Author
-
Cela V, Obino MER, Alberga Y, Pinelli S, Sergiampietri C, Casarosa E, Simi G, Papini F, and Artini PG
- Subjects
- Adult, Chorionic Gonadotropin administration & dosage, Chorionic Gonadotropin therapeutic use, Female, Fertilization in Vitro, Hormone Antagonists therapeutic use, Humans, Infertility, Female etiology, Pregnancy, Pregnancy Rate, Sperm Injections, Intracytoplasmic, Treatment Outcome, Young Adult, Gonadotropin-Releasing Hormone antagonists & inhibitors, Hormone Antagonists administration & dosage, Infertility, Female drug therapy, Ovary drug effects, Ovulation Induction methods, Polycystic Ovary Syndrome complications
- Abstract
Controlled ovarian stimulation (COH) in PCOS is a challenge for fertility expert both ovarian hyperstimulation syndrome (OHSS) and oocytes immaturity are the two major complication. Ovarian response to COH vary widely among POCS patients and while some patients are more likely to show resistance to COH, other experienced an exaggerated response. The aim of our study is to investigate a possible correlation between PCOS phenotypes and the variety of ovarian response to COH and ART outcomes in patients with different PCOS phenotypes. We retrospectively analyzed a total of 71 cycles performed in 44 PCOS infertile patients attending ART at Centre of Infertility and Assisted Reproduction of Pisa University between January 2013 and January 2016. Patientsundergoing IVF with GnRH-antagonist protocol and 150-225 UI/days of recombinant FSH; triggering was carried out using 250 mg of recombinant hCG or a GnRH analogous on the basis of the risk to OHSS. We observed that Phenotype B had a tendency to have a greater doses of gonadotropins used respect to all phenotypes. Phenotype A group showed a greater serum estrogen levels compared to all phenotypes groups, a greater number of follicles of diameter between 8-12 mm found by ultrasound on the day of triggering and a greater mean number of freeze embryo. Additionally serum AMH and antral follicles count (AFC) follow the same trend in the different phenotypes ad they were significantly higher in phenotype A and in phenotype D. In conclusion this study shows that the features of PCOS phenotypes reflect the variety of ovarian response to COH as well as the risks to develop OHSS. Serum AMH and AFC are related to the degree of ovulatory dysfunction making these 'added values' in identifying the different PCOS phenotypes. Phenotype A seems to be the phenotype with the higher risk to develop OHSS and the use of GnRH as a trigger seems to improve oocyte quality. To classify PCOS phenotype at diagnosis might help clinicians to identify patients at greater risk of OHSS, customize therapy and subsequently plan the trigger agent.
- Published
- 2018
- Full Text
- View/download PDF
34. Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.
- Author
-
Pinelli S, Artini PG, Basile S, Obino MER, Sergiampietri C, Giannarelli D, Simi G, and Cela V
- Subjects
- Adult, Chorionic Gonadotropin administration & dosage, Embryo Transfer, Estradiol analogs & derivatives, Estradiol blood, Estradiol therapeutic use, Female, Fertilization in Vitro methods, Follicle Stimulating Hormone blood, Humans, Infertility, Female etiology, Infertility, Female therapy, Male, Ovulation Induction methods, Pregnancy, Pregnancy Rate, Retrospective Studies, Estrogens therapeutic use, Infertility, Female drug therapy, Primary Ovarian Insufficiency physiopathology
- Abstract
Purpose: During the transitional phase of premature ovarian insufficiency (POI), sporadic resumption of ovulation is possible because of fluctuation of hormonal levels but the chance of spontaneous pregnancy is low, and the main perspective of childbearing in these women is egg donation or adoption. The purpose of the study was to verify whether treatment with estrogens in POI patients in transitional phase could reduce FSH levels and to evaluate if this pre-treatment could improve reproductive outcomes of in vitro fertilization (IVF)., Methods: Study patients (26) were administered with valerate estradiol 2 mg daily adding dihydrogesterone 10 mg daily during luteal phase for 3 months before IVF. Control group (26 patients) did not receive any pre-treatment. Ovarian stimulation was conducted in both groups with the same short GnRH-antagonist protocol. Clinical and laboratory data of patients were retrospectively analyzed., Results: In the study group, 4/26 POI patients became spontaneously pregnant during pre-treatment. In the remaining patients, the mean level of FSH after the pre-treatment was significantly reduced compared with baseline. Levels of circulating estradiol on the day of hCG administration were significantly higher in the study group. The total number of MII oocytes retrieved and fertilized oocytes was significantly higher in the study group, as well as the number of embryos transferred for pickup and clinical pregnancy rate., Conclusions: Treatment with estrogens in infertile POI patients in transitional phase reduces circulating FSH levels, hence causing potential spontaneous conception. Moreover, in these patients, estrogen pre-treatment seems to improve IVF outcomes in a GnRH-antagonist short protocol compared to no pre-treatment.
- Published
- 2018
- Full Text
- View/download PDF
35. PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome.
- Author
-
Artini PG, Obino MER, Sergiampietri C, Pinelli S, Papini F, Casarosa E, and Cela V
- Subjects
- Anovulation complications, Female, Humans, Laparoscopy, Obesity complications, Pregnancy, Pregnancy Outcome, Fertility Agents, Female therapeutic use, Infertility, Female therapy, Polycystic Ovary Syndrome complications
- Abstract
Introduction: Polycystic ovary syndrome (PCOS) is a common cause of female infertility affecting multiple aspects of a women's health., Areas Covered: The aim of this review is to summarize the existing evidence on the treatment of PCOS patients and to examine the actual available therapies to overcome the problem of infertility and improve the outcome of pregnancy. We analyse different treatment strategies such as lifestyle modification, bariatric surgery, insulin sensitizing agents, inositol, clomiphene citrate (CC), aromatase inhibitors, gonadotrophins, laparoscopic ovarian drilling, and assisted reproductive techniques (ART)., Expert Commentary: Lifestyle modification is the best initial management for obese PCOS patients seeking pregnancy and insulin sensitizing agents seem to have an important role in treating insulin resistance. Up to now, CC maintains a central role in the induction of ovulation and it has been confirmed as the first-line treatment; the use of gonadotrophins is considered the second-line in CC resistant patients; laparoscopic ovarian drilling is an alternative to gonadotrophins in patients who need laparoscopy for another reason. However, in anovulatory patients, ART represents the only possible alternative to obtain pregnancy. Larger and well-designed studies are needed to clarify the best way to improve the outcome of pregnancy in PCOS women.
- Published
- 2018
- Full Text
- View/download PDF
36. Cumulus cells surrounding oocytes with high developmental competence exhibit down-regulation of phosphoinositol 1,3 kinase/protein kinase B (PI3K/AKT) signalling genes involved in proliferation and survival.
- Author
-
Artini PG, Tatone C, Sperduti S, D'Aurora M, Franchi S, Di Emidio G, Ciriminna R, Vento M, Di Pietro C, Stuppia L, and Gatta V
- Subjects
- Adult, Animals, Cell Proliferation, Cell Survival, Down-Regulation, Female, Fertilization in Vitro, Gene Expression Profiling, Humans, Mice, Prognosis, Signal Transduction, Sperm Injections, Intracytoplasmic, Cumulus Cells metabolism, Gene Expression Regulation, Developmental, Oocytes cytology, Phosphatidylinositol 3-Kinases genetics, Proto-Oncogene Proteins c-akt genetics
- Abstract
Study Question: Is the phosphoinositol 1,3-kinase/protein kinase B (PI3K/AKT) pathway expression profile in cumulus cells (CCs) a potential marker of oocyte competence and predictive of pregnancy outcome?, Summary Answer: Eleven genes (AKT1, ARHGEF7, BCL2L1, CCND1, E2F1, HRAS, KCNH2, PIK3C2A, SHC1, SOS1 and SPP1) in the PI3K/AKT pathway were significantly down-regulated in CCs from oocytes that went on to produce a pregnancy compared to CCs associated with a negative outcome., What Is Known Already: The PI3K/AKT pathway plays a pivotal role in the interdependence and continuous feedback between the oocyte and CCs., Study Design Size, Duration: The expression analysis of 92 transcripts in the PI3K/AKT pathway in CCs from patients with negative or positive pregnancy outcome, after single embryo transfer, was performed. Mouse CCs target gene expression was conducted to associate the expression profile of PI3K/AKT pathway to oocyte developmental profile., Participants/materials, Setting, Methods: Fifty-five good prognosis IVF patients who had been referred to IVF or intracytoplasmic sperm injection treatment for male-factor infertility or tubal disease were enroled. CCs from single cumulus-oocyte complexes (COCs) from 16 patients who underwent a single embryo transfer were analyzed. Twenty-five CD-1 mice were used to assess gene expression in CCs associated with oocytes with different competence in relation to hCG priming. A total 220 human COCs were collected. The RNA extracted from CCs of 16 selected patients was used to analyze PI3K/AKT pathway gene expression employing a 96-well custom TaqMan Array. Expression data of CCs associated to positive IVF outcome were compared to data from negative outcome samples. Mice were sacrificed after 9, 12, 15, 21 and 24 h post-hCG administration to obtain CCs from MII oocytes with different developmental competence. Akt1, Bcl2l2 and Shc1 expression were tested in the collected mouse CCs. In addition, the expression of upstream regulator ESR1, the gene encoding for the oestrogen receptor ERβ, and the downstream effectors of the pathway FOXO1, FOXO3 and FOXO4 was evaluated in human and mouse samples., Main Results and the Role of Chance: Transcripts involved in the PI3K Signaling Pathway were selectively modulated according to the IVF/ICSI outcome of the oocyte. Eleven transcripts in this pathway were significantly down-regulated in all samples of CCs from oocytes with positive when compared those with a negative outcome. These outcomes were confirmed in mouse CCs associated with oocytes at different maturation stages. Expression data revealed that the down-regulation of ESR1 could be related to oocyte competence and is likely to be the driver of expression changes highlighted in the PI3K/AKT pathway., Limitations Reasons for Caution: Small sample size and retrospective design., Wider Implications of the Findings: The CCs expression profile of PI3K/AKT signaling genes, disclosed a specific CCs gene signature related to oocyte competence. It could be speculated that CCs associated with competent oocytes have completed their role in sustaining oocyte development and are influencing their fate in response to metabolic and hormonal changes by de-activating anti-apoptotic signals., Study Funding/competing Interest(s): Supported by Merck Serono an affiliate of Merck KGaA, Darmstadt, Germany (research grant for the laboratory session; Merck KGaA reviewed the manuscript for medical accuracy only before journal submission. The authors are fully responsible for the content of this manuscript, and the views and opinions described in the publication reflect solely those of the authors). The authors declare no conflict of interest., (© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.)
- Published
- 2017
- Full Text
- View/download PDF
37. Thyroid peroxidase identified in human granulosa cells: another piece to the thyroid-ovary puzzle?
- Author
-
Monteleone P, Faviana P, and Artini PG
- Subjects
- Female, Humans, Ovarian Follicle metabolism, Cumulus Cells metabolism, Granulosa Cells metabolism, Iodide Peroxidase metabolism
- Abstract
Thyroid hormones seemingly influence the maturation of the human oocyte. Thyroid hormone receptors have been isolated in granulosa mural and cumulus cells and the mature oocyte of the human ovarian follicle. Thyroid hormones are present in follicular fluid in concentrations similar to those in serum. Most importantly, enzymes involved in the chain that regulate the generation of thyroid hormones have been found in granulosa cells. For the first time, we have isolated thyroid peroxidase by immunocytochemistry in the granulosa cumulus cells of the human ovarian follicle, thereby supporting the hypothesis that the human ovarian follicle may be an independent thyroid-hormone producing unit.
- Published
- 2017
- Full Text
- View/download PDF
38. In vitro effect of myo-inositol on sperm motility in normal and oligoasthenospermia patients undergoing in vitro fertilization.
- Author
-
Artini PG, Casarosa E, Carletti E, Monteleone P, Di Noia A, and Di Berardino OM
- Subjects
- Adult, Humans, Male, Asthenozoospermia drug therapy, Fertilization in Vitro methods, Inositol pharmacology, Oligospermia drug therapy, Sperm Motility drug effects, Vitamin B Complex pharmacology
- Abstract
It is a known fact that abnormal seminal liquid specimens contain abnormal amounts of oxygen free radicals and reactive oxygen species (ROS), and that the use of antioxidant molecules both in vivo and in vitro leads to improvement of semen quality in terms of motility, reduction in DNA damage, with obvious consequences on the fertilization potential. Myo-inositol has been observed to have anti-oxidant properties and be present in much greater concentrations specifically in seminal liquid than in the blood. Moreover, there seems to be a direct relationship between myo-inositol and mitochondrial membrane potential (MMP) and sperm motility. Studies performed in vivo have demonstrated that a dietary supplementation with myo-inositol in men undergoing assisted reproduction techniques may improve sperm quality and motility in oligoasthenospermia (OAT) patients. In the following study we utilized myo-inositol in vitro to verify its effect on semen quality in both normal and OAT patients undergoing in vitro fertilization (IVF) with respect to standard sperm medium. In vitro incubation of seminal liquid carried out using myo-inositol (Andrositol-Lab, Lo.Li. Pharma-Roma, Italy) at a concentration of 15 μl/ml improved progressive motility in both normospermia and OAT subjects. In our opinion, myo-inositol may prove to be a useful strategy to improve sperm preparation for clinical use in IVF.
- Published
- 2017
- Full Text
- View/download PDF
39. The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.
- Author
-
Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, Artini PG, Provenzani A, Falone S, Carta G, D'Alessandro AM, Amicarelli F, and Tatone C
- Subjects
- Animals, Female, Humans, Mice, Ovary metabolism, Vitamin A analogs & derivatives, Carotenoids therapeutic use, Cyclophosphamide adverse effects, Mitochondria metabolism, Ovary drug effects, Sirtuin 1 metabolism, Tellurium therapeutic use
- Abstract
Cancer therapies are associated with increased infertility risk due to accelerated reproductive aging. Oxidative stress (OS) is a potential mechanism behind ovarian toxicity by cyclophosphamide (CPM), the most ovotoxic anticancer drug. An important sensor of OS is SIRT1, a NAD
+ -dependent deacetylase which regulates cellular defence and cell fate. This study investigated whether the natural carotenoid crocetin and the synthetic compound AS101 protect the ovary against CPM by modulating SIRT1 and mitochondrial markers. We found that the number of primordial follicles of female CD1 mice receiving crocetin plus CPM increased when compared with CPM alone and similar to AS101, whose protective effects are known. SIRT1 increased in CPM mouse ovaries revealing the occurrence of OS. Similarly, mitochondrial SIRT3 rose, whilst SOD2 and the mitochondrial biogenesis activator PGC1- α decreased, suggesting the occurrence of mitochondrial damage. Crocetin and AS101 administration prevented SIRT1 burst suggesting that preservation of redox balance can help the ovary to counteract ovarian damage by CPM. Decreased SIRT3 and increased SOD2 and PGC1- α in mice receiving crocetin or AS101 prior to CPM provide evidence for mitochondrial protection. Present results improve the knowledge of ovarian damage by CPM and may help to develop interventions for preserving fertility in cancer patients.- Published
- 2017
- Full Text
- View/download PDF
40. Inositol and In Vitro Fertilization with Embryo Transfer.
- Author
-
Simi G, Genazzani AR, Obino ME, Papini F, Pinelli S, Cela V, and Artini PG
- Abstract
Recently, studies on inositol supplementation during in vitro fertilization program (IVF) have gained particular importance due to the effect of this molecule on reducing insulin resistance improving ovarian function, oocyte quality, and embryo and pregnancy rates and reducing gonadotropin amount during stimulation. Inositol and its isoforms, especially myoinositol (MYO), are often used as prestimulation therapy in infertile patients undergoing IVF cycle. Inositol supplementation started three months before ovarian stimulation, resulting in significant improvements in hormonal responses, reducing the amount of FSH necessary for optimal follicle development and serum levels of 17beta-estradiol measured the day of hCG injection. As shown by growing number of trials, MYO supplementation improves oocyte quality by reducing the number of degenerated and immature oocytes, in this way increasing the quality of embryos produced. Inositol can also improve the quality of sperm parameters in those patients affected by oligoasthenoteratozoospermia.
- Published
- 2017
- Full Text
- View/download PDF
41. Inside the granulosa transcriptome.
- Author
-
D'Aurora M, Sperduti S, Di Emidio G, Stuppia L, Artini PG, and Gatta V
- Subjects
- Female, Humans, Fertilization in Vitro, Granulosa Cells physiology, Oocytes physiology, Ovulation Induction, Transcriptome physiology
- Abstract
The somatic component of follicular structure is a mixture of different cell types, represented by Granulosa cells (GCs) that are the paracrine regulators of the oocyte growth. GCs finely support this process by a continuous bidirectional talk with oocyte, which ensure oocyte quality and competence. Specific pathways are involved in the cross-talk and in both GCs and oocyte development. This review summarizes data from GCs gene expression analysis concerning both their physiological role and their interaction with oocyte. We also explore the CGs transcriptome modifications induced by controlled ovarian stimulation (COS) or pathological conditions and their impact in reproduction. The transcriptome analysis of GCs could be a powerful tool to improve our knowledge about the pathways involved in oocyte development. This approach, associated with new technologies as RNA-seq could allow the identifications of new noninvasive biological markers of oocyte quality to increase the efficiency of clinical IVF. Moreover, GCs expression analysis could be useful to shed light on new therapeutic targets by providing new options for the treatment of infertility.
- Published
- 2016
- Full Text
- View/download PDF
42. MicroRNAs Are Stored in Human MII Oocyte and Their Expression Profile Changes in Reproductive Aging.
- Author
-
Battaglia R, Vento ME, Ragusa M, Barbagallo D, La Ferlita A, Di Emidio G, Borzí P, Artini PG, Scollo P, Tatone C, Purrello M, and Di Pietro C
- Subjects
- Adult, Chromatin Assembly and Disassembly physiology, Computational Biology, DNA Methyltransferase 3A, Female, Gene Expression Profiling, Humans, MicroRNAs genetics, Aging metabolism, Gene Expression Regulation physiology, MicroRNAs metabolism, Oocytes metabolism
- Abstract
Maternal RNAs are synthesized by the oocyte during its growth; some of them are utilized for oocyte-specific processes and metabolism, others are stored and used during early development before embryonic genome activation. The appropriate expression of complex sets of genes is needed for oocyte maturation and early embryo development. In spite of the basic role of noncoding RNAs in the regulation of gene expression, few studies have analyzed their role in human oocytes. In this study, we identified the microRNAs (miRNAs) expressed in human metaphase II stage oocytes, and found that some of them are able to control pluripotency, chromatin remodeling, and early embryo development. We demonstrated that 12 miRNAs are differentially expressed in women of advanced reproductive age and, by bioinformatics analysis, we identified their mRNA targets, expressed in human oocytes and involved in the regulation of pathways altered in reproductive aging. Finally, we found the upregulation of miR-29a-3p, miR-203a-3p, and miR-494-3p, evolutionarily conserved miRNAs, also in aged mouse oocytes, and demonstrated that their overexpression is antithetically correlated with the downregulation of DNA methyltransferase 3A (Dnmt3a), DNA methyltransferase 3B (Dnmt3b), phosphatase and tensin homolog (Pten), and mitochondrial transcription factor A (Tfam). We propose that oocyte miRNAs perform an important regulatory function in human female germ cells, and their altered regulation could explain the changes occurring in oocyte aging., (© 2016 by the Society for the Study of Reproduction, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
43. Fertility-enhancing hysteroscopic surgery.
- Author
-
Cela V, Litta P, Franchini M, Sergiampietri C, Simi G, Freschi L, Artini PG, and Papini F
- Subjects
- Female, Fertilization in Vitro, Humans, Hysteroscopy adverse effects, Patient Compliance, Uterine Diseases complications, Uterus pathology, Uterus surgery, Hysteroscopy methods, Infertility, Female surgery, Uterine Diseases surgery
- Abstract
Anatomical uterine element and functional components play a fundamental role in the enhancing of fertility are the major actors. Uterine pathologies, including congenital or acquired lesions, have been reported in 21 to 47% of patients undergoing in vitro fertilization cycles. Hysteroscopy is an important procedure in the study of one of the most important element of fertility: the uterus, even if its use in the world of infertility is discussed. There are many studies on safety and feasibility of the procedure and on patient compliance, but there is no consensus on its systemic use. This study, thanks to the wide literature about the use of hysteroscopic surgery to enhance fertility in most of the congenital and acquired problems affecting women in fertility age, allows defining that diagnostic and operative hysteroscopy is a rapid and safety technology to improve fertility.
- Published
- 2016
44. Modulating Intrafollicular Hormonal Milieu in Controlled Ovarian Stimulation: Insights From PPAR Expression in Human Granulosa Cells.
- Author
-
Tatone C, Benedetti E, Vitti M, Di Emidio G, Ciriminna R, Vento ME, Cela V, Borzì P, Carta G, Lispi M, Cimini AM, and Artini PG
- Subjects
- Acyl Coenzyme A metabolism, Aromatase metabolism, Female, Follicle Stimulating Hormone pharmacology, Granulosa Cells drug effects, Humans, Intracellular Space drug effects, Intracellular Space metabolism, Luteinizing Hormone pharmacology, Ovarian Follicle drug effects, Protein Transport drug effects, Recombinant Proteins pharmacology, Retinoid X Receptors metabolism, Steroids biosynthesis, Granulosa Cells metabolism, Hormones metabolism, Ovarian Follicle metabolism, Ovulation Induction, Peroxisome Proliferator-Activated Receptors metabolism
- Abstract
Controlled ovarian stimulation (COS) leading to ovulation of multiple follicles is a crucial aspect of biomedical infertility care. Nevertheless, biomarkers useful for COS management are still lacking. Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors relevant to steroid metabolism in granulosa cells (GCs). We investigated whether PPARs and their steroidogenic targets were differentially expressed in GCs differentiated under different recombinant or urinary gonadotropin preparations. GCs from women subjected to COS with r-hFSH, r-hFSH/r-hLH, or hMG-HP were processed to assess expression of PPARα, PPARβ/δ, PPARγ, and steroidogenic enzymes under PPAR modulation. As an evidence of their activation, all PPAR isotypes with their coactivators, the retinoic-X-receptors (RXRs), localized in the nucleus. When GCs from r-hFSH/r-hLH group were compared with r-hFSH, a significant reduction of PPARα protein was observed. By contrast, an increase of PPARβ/δ at both protein and mRNA levels along with that of PPARγ protein were detected. The steroidogenic enzymes 17βHSD IV, 3βHSD II, and HMG-CoA red were downregulated in the r-hFSH/r-hLH group in comparison to r-hFSH unlike CYP19A1 that remained unchanged. In GCs from urinary FSH-LH stimulation (hMG-HP), PPARα was more expressed in comparison with r-hFSH/r-hLH group. Likewise, 3βHSD II and 17βHSD IV were increased suggesting that hMG-HP partially mimicked r-hFSH/r-hLH effects. In summary, transcript analysis associated to protein investigation revealed differential effects of COS protocols on PPARs and their steroidogenic targets in relation to LH and gonadotropin source. These observations candidate PPARs as new biomarkers of follicle competence opening new hypotheses on COS effects on ovarian physiology. J. Cell. Physiol. 231: 908-914, 2016. © 2015 Wiley Periodicals, Inc., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
45. Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility.
- Author
-
Vitti M, Di Emidio G, Di Carlo M, Carta G, Antonosante A, Artini PG, Cimini A, Tatone C, and Benedetti E
- Abstract
Reproductive functions may be altered by the exposure to a multitude of endogenous and exogenous agents, drug or environmental pollutants, which are known to affect gene transcription through the peroxisome proliferator-activated receptors (PPARs) activation. PPARs act as ligand activated transcription factors and regulate metabolic processes such as lipid and glucose metabolism, energy homeostasis, inflammation, and cell proliferation and differentiation. All PPARs isotypes are expressed along the hypothalamic-pituitary-gonadal axis and are strictly involved in reproductive functions. Since female fertility and energy metabolism are tightly interconnected, the research on female infertility points towards the exploration of potential PPARs activating/antagonizing compounds, mainly belonging to the class of thiazolidinediones (TZDs) and fibrates, as useful agents for the maintenance of metabolic homeostasis in women with ovarian dysfunctions. In the present review, we discuss the recent evidence about PPARs expression in the hypothalamic-pituitary-gonadal axis and their involvement in female reproduction. Finally, the therapeutic potential of their manipulation through several drugs is also discussed.
- Published
- 2016
- Full Text
- View/download PDF
46. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
- Author
-
Simi G, Obino ME, Casarosa E, Litta P, Artini PG, and Cela V
- Subjects
- Academic Medical Centers, Adult, Female, Follicular Phase, Gonadotropins administration & dosage, Humans, Luteal Phase, Oocyte Retrieval methods, Ovulation Induction methods, Retrospective Studies, Cryopreservation methods, Fertility Preservation methods, Neoplasms drug therapy, Neoplasms radiotherapy, Oocytes
- Abstract
Objective: To analyze the results obtain in cancer patients who receive the same controlled ovarian stimulation protocol, started in two different moments of the menstrual cycle, follicular or luteal phase. The stimulation is performed before cancer treatment in order to preserve fertility through oocytes cryopreservation., Study Design: The study is a retrospective analysis about 25 cancer patients at our centre, Department of Reproductive Medicine of University of Pisa, in order to preserve their fertility before cancer treatment. Patients are divided into two groups depending on the menstrual cycle phase, follicular or luteal phase, at the moment of first examination. Standard stimulation protocol with gonadotropins is administered in the follicular group, whereas in the second group we use GnRH (gonadotropin-releasing hormone) antagonist before gonadotropins administration in order to have a rapid luteolysis. The outcome measures are the number of days needed before starting procedure, duration of stimulation, cumulative dosage of gonadotropins number of oocyte retrieved and percentage of mature oocytes., Results: Any difference showed between two groups based on days of stimulation, total amount of gonadotropins administered and the number of good mature quality oocytes was retrieved. The real difference is the number of days needed to start the procedure, lesser in the luteal group., Conclusions: This study suggests that oocytes can be obtained before cancer treatment, irrespective of menstrual cycle phase without compromising the efficacy of procedure. Moreover, starting ovarian stimulation anytime during menstrual cycle allows the patients to not postpone the beginning of cancer treatment. Different stimulation protocols, according to different kinds of disease, are available in order to obtain the maximum results without any complication for patients.
- Published
- 2015
- Full Text
- View/download PDF
47. Increased levels of oxidative and carbonyl stress markers in normal ovarian cortex surrounding endometriotic cysts.
- Author
-
Di Emidio G, D'Alfonso A, Leocata P, Parisse V, Di Fonso A, Artini PG, Patacchiola F, Tatone C, and Carta G
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Adult, Biomarkers metabolism, Deoxyguanosine analogs & derivatives, Deoxyguanosine metabolism, Endometriosis pathology, Female, Forkhead Box Protein O3, Forkhead Transcription Factors metabolism, Glycation End Products, Advanced metabolism, Humans, Ovarian Cysts pathology, Ovary pathology, Retrospective Studies, Young Adult, Endometriosis metabolism, Ovarian Cysts metabolism, Ovary metabolism, Oxidative Stress physiology
- Abstract
Many evidence support the view that endometriotic cyst may exert detrimental effect on the surrounding ovarian microenvironment so representing a risk to functionality of adjacent follicles. Patients with benign ovarian cyst (endometriotic, follicular and dermoid cysts) subjected to laparoscopic cystectomy were enrolled in the present retrospective study in order to analyze whether endometriotic tissue could negatively affect the surrounding normal ovarian cortex more severely than other ovarian cysts. To this end we carried out immunohistochemistry analysis and comparative determination of the transcription factor FOXO3A, oxidized DNA adduct 8-OHdG (8-hydroxy-2'-deoxyguanosine) and damaged proteins known as AGEs (Advanced Glycation End products) as markers of ovarian stress response and molecular damage. Our results show that all the markers analyzed were present in normal ovarian tissue surrounding benign cysts. We observed higher levels of FOXO3A (15.90 ± 0.28), 8-OHdG (13.33 ± 2.07) and AGEs (12.58 ± 4.34) staining in normal ovarian cortex surrounding endometriotic cysts in comparison with follicular cysts (9.04 ± 0.29, 2.67 ± 2.67, 11.31 ± 2.95, respectively) and dermoid cysts (2.02 ± 0.18, 4.33 ± 2.58 and 10.56 ± 4.03, respectively). These results provide evidence that ovarian endometrioma is responsible for more severe alterations to cellular biomolecules than follicular and dermoid cysts.
- Published
- 2014
- Full Text
- View/download PDF
48. Over hypothyroidism in a woman undergoing controlled ovarian hyperstimulation.
- Author
-
Del Ghianda S, Loconte E, Ruggiero M, Benelli E, Artini PG, Cela V, Simoncini T, Latrofa F, Vitti P, and Tonacchera M
- Abstract
Objective: Thyroid function and gonadal axis are related throughout a woman's fertile period. Modifications of thyroid hormone levels have been reported as a consequence of controlled ovarian stimulation for infertility., Methods: A 28-year-old woman with regular menses and previous evidence of euthyroidism underwent controlled ovarian hyperstimulation (COH) for assisted reproductive technology (ART). Free thyroxine (FT4), free triiodothyronine (FT3), thyroid-stimulating hormone (TSH), and autoantibodies against thyroperoxidase and thyroglobulin (TPOAb and TgAb, respectively) were measured before COH. FT4, FT3, and TSH were re-evaluated 6 days, 2 weeks (during oocyte retrieval), and 1 month after the beginning of the procedure., Results: The baseline evaluation revealed subclinical autoimmune hypothyroidism. The patient was hypothyroidic at 6 days and 2 weeks and spontaneously returned to euthyroidism 1 month after COH., Conclusion: This is the first case of a woman with an unknown subclinical autoimmune hypothyroidism who developed overt and transient hypothyroidism as a consequence of COH. Careful thyroid evaluation is advised for women undergoing COH.
- Published
- 2014
- Full Text
- View/download PDF
49. Conventional IVF as a laboratory strategy to rescue fertility potential in severe poor responder patients: the impact of reproductive aging.
- Author
-
Artini PG, Obino ME, Carletti E, Pinelli S, Ruggiero M, Di Emidio G, Cela V, and Tatone C
- Subjects
- Adult, Cohort Studies, Female, Gonadotropin-Releasing Hormone antagonists & inhibitors, Gonadotropins pharmacology, Humans, Infertility, Female physiopathology, Italy epidemiology, Oocyte Retrieval, Oogenesis drug effects, Ovary pathology, Ovary physiopathology, Pregnancy, Pregnancy Rate, Retrospective Studies, Sperm Injections, Intracytoplasmic adverse effects, Aging, Drug Resistance, Fertility Agents, Female pharmacology, Fertilization in Vitro adverse effects, Infertility, Female therapy, Ovary drug effects, Ovulation Induction adverse effects
- Abstract
Objective: To investigate whether laboratory strategies can improve in vitro fertilization (IVF) outcome in poor responder patients. We compared the effectiveness of conventional IVF and intra cytoplasmic sperm injection (ICSI) in assisted reproductive technologies cycles in which only one or two oocytes were retrieved at ovarian pick up, in the absence of male infertility., Design: Retrospective analysis of 425 cycles in 386 poor responder patients., Intervention(s): Standard stimulation protocol with gonadotropins and gonadotropin releasing hormone (GnRH) antagonist., Main Outcome Measure(s): Fertilization rate, cleavage rate, good-quality embryo rate, implantation rate, clinical pregnancy rate (PR) and miscarriage rate., Results: IVF was found to be more advantageous for implantation and PR, especially in patients under 35 years and in women aged between 35 and 38 years. No differences were noted in the other parameter evaluated. Patients aged over 38 years showed no difference using the two techniques., Conclusion: The employment of ICSI in the absence of a male factor can reduce reproductive outcome in poor responder. Probably because of aging-related defects overcoming the advantage of sperm selection, the choice of IVF technique is not relevant to reproductive success when oocyte quality is compromised by reproductive aging. Although further randomized trials are needed to confirm our results, we propose that, in absence of male infertility, conventional IVF might be the technique of choice in young patients, especially in those aged below 35 years.
- Published
- 2013
- Full Text
- View/download PDF
50. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
- Author
-
Gatta V, Tatone C, Ciriminna R, Vento M, Franchi S, d'Aurora M, Sperduti S, Cela V, Borzì P, Palermo R, Stuppia L, and Artini PG
- Subjects
- Adult, Cluster Analysis, Cumulus Cells metabolism, Drug Therapy, Combination, Female, Gene Expression Regulation, Gene Regulatory Networks, Humans, Infertility, Female genetics, Oligonucleotide Array Sequence Analysis, Oocyte Retrieval, RNA, Messenger metabolism, Recombinant Proteins therapeutic use, Reverse Transcriptase Polymerase Chain Reaction, Time Factors, Treatment Outcome, Cumulus Cells drug effects, Fertility Agents, Female therapeutic use, Follicle Stimulating Hormone, Human therapeutic use, Gene Expression Profiling methods, Gonadotropins therapeutic use, Infertility, Female therapy, Luteinizing Hormone therapeutic use, Ovulation Induction methods
- Abstract
Objective: To evaluate cumulus cell (CC) expression profile modulation after different stimulation protocols., Design: CCs transcriptome variations were evaluated by microarray in patients undergoing different treatments for ovarian stimulation, namely, r-hLH + r-hFSH and hp-hMG, compared with a control group treated with r-hFSH., Setting: Healthy patients undergoing assisted reproduction protocols., Patient(s): Sixteen healthy women with regular cycles and tubal disease or unexplained infertility., Intervention(s): Four patients received hp-hMG, four received r-hFSH + r-hLH, and eight received r-hFSH daily. Aspiration of the oocytes was performed 36 hours after hCG administration. Only samples derived from cumulus-oocyte complexes containing mature oocytes showing polar body were processed., Main Outcome Measure(s): Comparison of genes differentially expressed in both treatment groups with the use of a hierarchic clustering analysis., Result(s): Data clustering analysis allowed detection of four clusters containing genes differentially expressed in both treatment groups compared with control. Functional analysis of the affected transcripts revealed genes involved in oocyte development and maturation., Conclusion(s): r-hLH and hCG, though acting on the same receptor, produce a differential activation of intracellular pathways. It can be hypothesized that this effect depends on their different structures and specific binding affinity for the receptor., (Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.